← brief for 2026-11-12 · Slowing decline
Baseline SGLT2 inhibitor use and documented ascites after a first ascites hospitalization: a retrospective two-center cohort study.
Key takeaways
This study looked at people with liver disease and diabetes who were hospitalized for fluid buildup. It found that taking a certain diabetes drug, called an SGLT2 inhibitor, was linked to less fluid buildup during follow-up. This shows a link, not proof of cause, but it may help manage fluid in these patients.
Who did this work
Riado Mínguez D · Parra Villanueva FJ · Rodríguez Heinsen AC · Fernández-Gordón Sánchez FMª · Agudo Fernández S · Cuadrado Tiemblo C · Bejerano Domínguez A · Castaño Milla C
Source
Article · PubMed, the drug frontier · 2026 Nov 12
https://pubmed.ncbi.nlm.nih.gov/43018354/